info iconCurrently, the share price for Suven Pharmaceuticals Ltd. is delayed.

close icon
Suven Pharmaceuticals Ltd. Logo

Suven Pharmaceuticals Ltd.

₹1,309.10
NSE
--   ( -- %) 1D



  • Prev. Close
    1,309.10
  • Upper Circuit
    1,570.90
  • Lower Circuit
    1,047.30

Analyst Sentiment For Suven Pharmaceuticals Ltd.

Info icon
There seem to be no recommendations on this stock from the analyst universe covered
Created with Highcharts 7.2.2N/AN/AN/AN/AN/AN/APositiveNeutralNegative

Returns

Created with Highcharts 7.2.2623.00%623.00%321.00%321.00%3248.00%3248.00%12065.00%12065.00%15173.13%15173.13%65928.67%65928.67%1 Week1 Month3 Months1 Year3 Year5 Year

Suven Pharmaceuticals Ltd.'s Info & Management

Suven Pharmaceuticals is a bio-pharmaceutical company, with the object of being engaged in the business of development and manufacturing of New Chemical Entity (NCE) based Intermediates, Active Pharmaceutical Ingredients (API), Specialty Chemicals and formulated drugs under contract research and manufacturing services for global pharmaceutical, biotechnology and chemical companies.
  • Chief Executive Officer
    Dr Sudhir Kumar Singh
  • Chief Financial Officer
    Mr Himanshu Agarwal
  • Chief Human Resources Officer
    Mr Gaurav Narain Bahadur
  • Chief Strategy Officer
    Mr Subba Raju Komaravolu
  • Senior Vice President
    E Esakki Ramkumar
  • Vice President
    Singi Venkat Subba Reddy

FAQs on Suven Pharmaceuticals Ltd.

What is the share price of Suven Pharmaceuticals Ltd.?

Suven Pharmaceuticals Ltd. share price is ₹1,296.00 as of December 3, 2024, 03:29 PM. Share/stock prices are volatile and change over the course of a trading day, and may differ basis on exchange (NSE/BSE).

What is the 52-week high and low of Suven Pharmaceuticals Ltd.?

The 52-week high and low of Suven Pharmaceuticals Ltd. is ₹1,360.00 and ₹587.05 respectively as of December 3, 2024, 03:29 PM. 52-week high and low represent the maximum and minimum value of the share price respectively, over the last 52 weeks (similar to 1 year).

What is the PB ratio of Suven Pharmaceuticals Ltd.?

The trailing twelve month (TTM) PB ratio of Suven Pharmaceuticals Ltd. is 16.25 as of December 4, 2024. The PB ratio measures the market capitalization of the company relative to it’s book value (carrying value on the balance sheet) as of last reported period.

What are the Upper Circuit and Lower Circuit of Suven Pharmaceuticals Ltd.?

The Upper Circuit of Suven Pharmaceuticals Ltd. is ₹1,571. The Lower Circuit of Suven Pharmaceuticals Ltd. is ₹1,047.

What is the ROE of Suven Pharmaceuticals Ltd.?

Suven Pharmaceuticals Ltd. reported an ROE of 15.86% for the last reported financial year on a consolidated account basis. Return on Equity (ROE) reflects how efficiently the company is able to generate profit as a percent of their equity financing.

What is the shareholding pattern of Suven Pharmaceuticals Ltd.?

Shareholding pattern gives insights on the concentration of holdings towards various groups of investors. As of last reported quarter for Suven Pharmaceuticals Ltd., Promoter held 50.1%, the FII held 10.7%, DII held 17% and the public held 22.3% of the total shares.

How to buy Suven Pharmaceuticals Ltd. Share?

You can easily buy shares of Suven Pharmaceuticals Ltd. online through Share.Market. If you are an existing user, login to your account, else follow the process to create your own Demat and Trading account in a few easy steps.

What is the fair value of Suven Pharmaceuticals Ltd.?

The fair value of Suven Pharmaceuticals Ltd. is an estimated price at which buyers and sellers would freely trade their shares. The various ways to determine the fair value of an asset include looking at recent market transactions for similar assets, estimating its expected earnings or the cost of replacing it.
Trademarks owned by their respective owners and shown here only for ease of recall of the respective owner by public.Disclaimer